Relief Therapeutics to receive European patent covering RLF-TD011 for epidermolysis bullosa wound treatment: Geneva Tuesday, October 22, 2024, 13:00 Hrs [IST] Relief Therapeutics ...

Hyperammonemia Treatment MarketThe global hyperammonemia treatment market size is expected to reach a valuation of USD ...

The Swiss market recently exhibited a mixed performance, with the benchmark SMI index experiencing fluctuations and closing slightly lower, while some companies like Relief Therapeutics saw ...

Biovica, active in blood-based cancer monitoring, has signed a Master Service Agreement (MSA) for TKa testing with a UK-based pharma biotech company.Under this agreement, Biovica ...

International medical imaging IT and cybersecurity company Sectra's (STO: SECT B) SaaS in the cloud, Sectra One Cloud, will be used by Barking, Havering and Redbridge University Hospitals NHS Trust ...

Revance Therapeutics, Inc. (NASDAQ: RVNC )'s sale to Crown Laboratories, Inc. for $6.66 per share in cash. If you are a Revance shareholder, click here to learn more about your rights and options .

Zylem Biosciences, a company specializing in cancer and cardiovascular therapeutics, announced that Northwestern University has filed a lawsuit against Moderna, alleging infringement of key patents ...

The firm says it could offer an alternative to existing treatments while sidestepping addiction concerns that have plagued ...

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Pain Management Devices Market, Industry Trends and Global Forecasts to 2035: ...

Trevi Therapeutics (TRVI) announced that it has completed enrollment in its Phase 2a trial for the treatment of RCC and expects to report ...

Stoke had a penalty call turned down when Junho flicked a pass from Koumas into the arm of George Tanner and referee David ...